Thymus clues may help shield immune system during lung cancer radiation
NCT ID NCT07564089
First seen May 12, 2026 · Last updated May 14, 2026 · Updated 1 time
Summary
This study looks at whether the size and shape of the thymus gland, along with the radiation dose it receives, can predict a drop in immune cells (lymphopenia) after radiation therapy for stage III lung cancer. Researchers will collect data from standard scans and blood tests of 450 adults receiving chest radiation. The goal is to help doctors design safer radiation plans in the future. This is an observational study with no added treatments or risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION-INDUCED LYMPHOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.